Health Catalyst, Inc.
HCAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $426 | $522 | $571 | $1,882 |
| - Cash | $250 | $106 | $116 | $193 |
| + Debt | $402 | $249 | $248 | $205 |
| Enterprise Value | $578 | $665 | $703 | $1,893 |
| Revenue | $307 | $296 | $276 | $242 |
| % Growth | 3.6% | 7.1% | 14.2% | – |
| Gross Profit | $141 | $132 | $133 | $118 |
| % Margin | 45.9% | 44.5% | 48.2% | 48.6% |
| EBITDA | -$11 | -$68 | -$83 | -$102 |
| % Margin | -3.5% | -23.1% | -30% | -42% |
| Net Income | -$70 | -$118 | -$137 | -$153 |
| % Margin | -22.7% | -39.9% | -49.7% | -63.3% |
| EPS Diluted | -1.15 | -2.09 | -2.54 | -3.23 |
| % Growth | 45% | 17.7% | 21.4% | – |
| Operating Cash Flow | $15 | -$33 | -$35 | -$23 |
| Capital Expenditures | -$16 | -$14 | -$17 | -$18 |
| Free Cash Flow | -$2 | -$47 | -$53 | -$42 |